SCHEMBL7181935

SCHEMBL7181935

CCCC(=O)OC(=O)OC(C)(C)C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.58
HDAC1 Q13547 5/20 0.37
HDAC2 Q92769 5/20 0.37
HDAC6 Q9UBN7 3/20 0.37
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
HDAC3 O15379 4/20 0.33
HDAC8 Q9BY41 4/20 0.33
FFAR3 O14843 3/20 0.33
CA12 O43570 3/20 0.33
CA14 Q9ULX7 3/20 0.33
CA1 P00915 2/20 0.33
CA7 P43166 1/20 0.33
LMNA P02545 1/20 0.33
ELANE P08246 1/20 0.32
TSHR P16473 1/20 0.32
CTSK P43235 1/20 0.32
DGAT1 O75907 1/20 0.31
SOAT1 P35610 1/20 0.31
PRSS1 P07477 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7173579 0.86 DGKA (0.47) ALDH1A1HDAC1HDAC2HDAC6CES2
SCHEMBL28960055 0.84 HDAC6 (0.46) ALDH1A1HDAC1HDAC2HDAC6HDAC3
SCHEMBL28657457 0.84 DGKA (0.50) ALDH1A1HDAC1HDAC2HDAC6CES2
SCHEMBL30733885 0.84 DGKA (0.50) ALDH1A1HDAC1HDAC2HDAC6CES2
SCHEMBL8882125 0.84 DGKA (0.50) ALDH1A1HDAC1HDAC2HDAC6CES2
SCHEMBL28061441 0.84 HDAC6 (0.36) ALDH1A1HDAC1HDAC2HDAC6FFAR3
SCHEMBL10446 0.81 ALDH1A1 (0.55) ALDH1A1HDAC1HDAC2HDAC6CES2
SCHEMBL11667508 0.81 ALDH1A1 (0.78) ALDH1A1HDAC1HDAC2HDAC6CES2
SCHEMBL15359353 0.81 HDAC6 (0.36) ALDH1A1HDAC1HDAC2HDAC6HDAC3
SCHEMBL1827760 0.81 HDAC6 (0.36) ALDH1A1HDAC1HDAC2HDAC6HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4319746-A1 METHODS OF TREATING METHYLMALONIC ACIDEMIA AND PROPIONIC ACIDEMIA Hemoshear Therapeutics, Inc. (US) 2024-02-14 EP disclosed
CN-115876926-A Method for detecting BOC butyric acid in water and algae culture medium by using HPLC-MS/MS 贵州健安德科技有限公司 2023-03-31 CN disclosed
WO-2022216848-A1 METHODS OF TREATING METHYLMALONIC ACIDEMIA AND PROPIONIC ACIDEMIA Hemoshear Therapeutics, Inc. (US) 2022-10-13 WO disclosed
CN-106986837-A A kind of preparation method of azole compounds 湖南华腾制药有限公司 2017-07-28 CN disclosed
US-6576664-B1 1-amido-2-hydroxy-substituted-indanes; suppressing production of tumor necrosis factor BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-06-10 US disclosed
CN-1268117-A Novel inhibitors of aggrecanase and matrix metalloproteinases for the treatment of arthritis DU PONT PHARM CO (US) 2000-09-27 CN disclosed
CN-1257482-A Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonist GLAXO WELLCOME SPA (IT) 2000-06-21 CN disclosed
EP-1005448-A2 NOVEL INHIBITORS OF AGGRECANASE AND MATRIX METALLOPROTEINASES FOR THE TREATMENT OF ARTHRITIS Du Pont Pharmaceuticals Company (US) 2000-06-07 EP disclosed
WO-1999009000-A2 NOVEL INHIBITORS OF AGGRECANASE AND MATRIX METALLOPROTEINASES FOR THE TREATMENT OF ARTHRITIS DU PONT PHARMACEUTICALS COMPANY (US) 1999-02-25 WO disclosed